Literature DB >> 22147568

Mammalian cell HPRT gene mutation assay: test methods.

George E Johnson1.   

Abstract

Using the combination of bacterial gene mutation assay and chromosomal aberrations test in mammalian cells may not detect a small proportion of mammalian specific mutagenic agents. Therefore, at the current time a third assay should be used, except for compounds for which there is little or no exposure (DOH (2000) Department of Health Guidance for the testing of chemicals for Mutagenicity. Committee on Mutagenicity of Chemicals in Food, Consumer Products and the Environment). The hypoxanthine phosphorybosyl transferase (HPRT) gene is on the X chromosome of mammalian cells, and it is used as a model gene to investigate gene mutations in mammalian cell lines. The assay can detect a wide range of chemicals capable of causing DNA damage that leads to gene mutation. The test follows a very similar methodology to the thymidine kinase (TK) mouse lymphoma assay (MLA), and both are included in the guidelines for mammalian gene mutation tests (OECD (1997) Organisation for Economic Co-operation and Development. Ninth addendum to the OECD Guidelines for the Testing of Chemicals. In Vitro Mammalian Cell Gene Mutation Test: 476). The HPRT methodology is such that mutations which destroy the functionality of the HPRT gene and or/protein are detected by positive selection using a toxic analogue, and HPRT ( - ) mutants are seen as viable colonies. Unlike bacterial reverse mutation assays, mammalian gene mutation assays respond to a broad spectrum of mutagens, since any mutation resulting in the ablation of gene expression/function produces a HPRT ( - ) mutant. Human cells are readily used, and mechanistic studies using the HPRT test methodology with modifications, such as knock-out cell lines for DNA repair, can provide details of the mode of action (MOA) of the test compound (24).This chapter provides the methodology for carrying out the assay in different cell lines in the presence and absence of metabolism with technical information and general advice on how to carry out the test.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22147568     DOI: 10.1007/978-1-61779-421-6_4

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  30 in total

1.  Assessment of cytotoxicity, genotoxicity and 7-ethoxyresorufin-O-deethylase (EROD) induction in sediment extracts from New Zealand urban estuaries.

Authors:  Patrick Heinrich; Lara L Petschick; Grant L Northcott; Louis A Tremblay; James M Ataria; Thomas Braunbeck
Journal:  Ecotoxicology       Date:  2017-01-12       Impact factor: 2.823

2.  ZSCAN10 expression corrects the genomic instability of iPSCs from aged donors.

Authors:  Maria Skamagki; Cristina Correia; Percy Yeung; Timour Baslan; Samuel Beck; Cheng Zhang; Christian A Ross; Lam Dang; Zhong Liu; Simona Giunta; Tzu-Pei Chang; Joye Wang; Aparna Ananthanarayanan; Martina Bohndorf; Benedikt Bosbach; James Adjaye; Hironori Funabiki; Jonghwan Kim; Scott Lowe; James J Collins; Chi-Wei Lu; Hu Li; Rui Zhao; Kitai Kim
Journal:  Nat Cell Biol       Date:  2017-08-28       Impact factor: 28.824

3.  EGFR-TKI-induced HSP70 degradation and BER suppression facilitate the occurrence of the EGFR T790 M resistant mutation in lung cancer cells.

Authors:  Xiang Cao; Yi Zhou; Hongfang Sun; Miao Xu; Xiaowen Bi; Zhihui Zhao; Binghui Shen; Fengyi Wan; Zhuan Hong; Lei Lan; Lan Luo; Zhigang Guo; Zhimin Yin
Journal:  Cancer Lett       Date:  2018-03-07       Impact factor: 8.679

Review 4.  The placenta in toxicology. Part IV: Battery of toxicological test systems based on human placenta.

Authors:  Claudia Göhner; Judit Svensson-Arvelund; Christiane Pfarrer; Jan-Dirk Häger; Marijke Faas; Jan Ernerudh; J Mark Cline; Darlene Dixon; Eberhard Buse; Udo R Markert
Journal:  Toxicol Pathol       Date:  2013-04-02       Impact factor: 1.902

5.  A Rapid and Precise Mutation-Activated Fluorescence Reporter for Analyzing Acute Mutagenesis Frequency.

Authors:  Michael D Birnbaum; Leah Nemzow; Akhilesh Kumar; Feng Gong; Fangliang Zhang
Journal:  Cell Chem Biol       Date:  2018-06-14       Impact factor: 8.116

6.  TGFβ induces "BRCAness" and sensitivity to PARP inhibition in breast cancer by regulating DNA-repair genes.

Authors:  Liang Liu; Weiying Zhou; Chun-Ting Cheng; Xiubao Ren; George Somlo; Miranda Y Fong; Andrew R Chin; Hui Li; Yang Yu; Yang Xu; Sean Timothy Francis O'Connor; Timothy R O'Connor; David K Ann; Jeremy M Stark; Shizhen Emily Wang
Journal:  Mol Cancer Res       Date:  2014-08-07       Impact factor: 5.852

7.  Spironolactone Depletes the XPB Protein and Inhibits DNA Damage Responses in UVB-Irradiated Human Skin.

Authors:  Michael G Kemp; Smita Krishnamurthy; Michael N Kent; David L Schumacher; Priyanka Sharma; Katherine J D A Excoffon; Jeffrey B Travers
Journal:  J Invest Dermatol       Date:  2018-09-15       Impact factor: 8.551

8.  ATR kinase inhibition sensitizes quiescent human cells to the lethal effects of cisplatin but increases mutagenesis.

Authors:  Rebekah J Hutcherson; Michael G Kemp
Journal:  Mutat Res       Date:  2019-09-17       Impact factor: 2.433

9.  β-d-N4-hydroxycytidine Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells.

Authors:  Shuntai Zhou; Collin S Hill; Sanjay Sarkar; Longping V Tse; Blaide M D Woodburn; Raymond F Schinazi; Timothy P Sheahan; Ralph S Baric; Mark T Heise; Ronald Swanstrom
Journal:  J Infect Dis       Date:  2021-08-02       Impact factor: 5.226

10.  MIF is a 3' flap nuclease that facilitates DNA replication and promotes tumor growth.

Authors:  Yijie Wang; Yan Chen; Chenliang Wang; Mingming Yang; Yanan Wang; Lei Bao; Jennifer E Wang; BongWoo Kim; Kara Y Chan; Weizhi Xu; Emanuela Capota; Janice Ortega; Deepak Nijhawan; Guo-Min Li; Weibo Luo; Yingfei Wang
Journal:  Nat Commun       Date:  2021-05-19       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.